[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340980-105":59,"doc-detail-340980-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","upregulation-of-poc1a-in-lung-adenocarcinoma-promotes-tumour-progression-and-predicts-poor-prognosis","Upregulation of POC1A in lung adenocarcinoma promotes tumour progression and predicts poor prognosis","","Lung adenocarcinoma (LUAD) has high incidence and mortality, yet the role of POC1 centriolar protein A (POC1A) in LUAD is unclear. Data mining of TCGA and GEO evaluated POC1A differential expression and links to clinical stage, diagnostic performance by ROC, and prognostic value by Kaplan–Meier analysis. Correlations were further tested against immune infiltration, tumour mutation burden, immune checkpoint expression, and drug sensitivity, with validation by RT-qPCR and IHC, plus cell assays of proliferation, migration, and invasion.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/upregulation-of-poc1a-in-lung-adenocarcinoma-promotes-tumour-progression-and-predicts-poor-prognosis/340980/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/upregulation-of-poc1a-in-lung-adenocarcinoma-promotes-tumour-progression-and-predicts-poor-prognosis/340980.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim of the study on POC1A in lung adenocarcinoma?","Question",{"text":112,"@type":113},"The study evaluates whether POC1A expression is associated with LUAD development, diagnosis performance, and poor prognosis, and explores related immune and genomic features.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was POC1A diagnostic and prognostic value assessed?",{"text":117,"@type":113},"Differential expression was analyzed using TCGA and GEO, diagnostic performance was tested using ROC curve analysis, and prognostic value was evaluated using Kaplan–Meier survival analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental methods validated the findings for POC1A?",{"text":121,"@type":113},"POC1A expression was verified using real-time quantitative PCR and immunohistochemistry, and cell experiments tested effects of POC1A on proliferation, migration, and invasion.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340980,1790167684,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","DOI: 10. 1111/jcmm.18135  \nOR I G I NAL ART I C L E  \nUpregulation of POC1A in lung adenocarcinoma promotes tumour progression and predicts poor prognosis  \nZi-Hao Li1 | Jia-Yi Li2 | Zuo-Tao Wu1 | Yong-Jie Zhu1 | Ting Zhuo3 | Ju-Sen Nong4 | Jing Qian1 | Hua-Jian Peng1 | Lei Dai1 | Yong-Yong Wang1 | Ming-Wu Chen1 | Xiao-Chun Zeng1   \n1Department of Cardio-Thoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China  \n2Geriatrics Department of Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China  \n3 Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China  \n4Department of Pediatric Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China  \nCorrespondence  \nXiao-Chun Zeng and Ming-Wu Chen, Department of Cardio-Thoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.  \nEmail: [zengxiaochun@gxmu.edu.cn](zengxiaochun@gxmu.edu.cn) and [chen535@126.com](chen535@126.com)  \nFunding information  \nApplied Project of Guangxi Health and Medical Appropriate Technology in Development and Promotion, Grant/ Award Number: S2019105  \nAbstract  \nLung adenocarcinoma (LUAD) is characterized by a high incidence rate and mortality. Recently, POC1 centriolar protein A (POC1A) has emerged as a potential biomarker for various cancers, contributing to cancer onset and development. However, the association between POC1A and LUAD remains unexplored. We extracted The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) data sets to analyse the differential expression of POC1A and its relationship with clinical stage. Additionally, we performed diagnostic receiver operator characteristic (ROC) curve analysis and Kaplan–Meier (KM) survival analysis to assess the diagnostic and prognostic value of POC1A in LUAD. Furthermore, we investigated the correlation between POC1A expression and immune infiltration, tumour mutation burden (TMB), immune checkpoint expression and drug sensitivity. Finally, we verified POC1A expression using real-time quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry (IHC) . Cell experiments were conducted to validate the effect of POC1A expression on the proliferation, migration and invasion of lung cancer cells. POC1A exhibited overexpression in most tumour tissues, and its overexpression in LUAD was significantly correlated with late-stage presentation and poor prognosis. The high POC1A expression group showed lower levels of immune infiltration but higher levels of immune checkpoint expression and TMB. Moreover, the high POC1A expression group demonstrated sensitivity to multiple drugs. In vitro experiments confirmed that POC1Aknockdown led to decreased proliferation, migration, and invasion of lung cancer cells. Our findings suggest that POC1A may contribute to tumour development by modulating the cell cycle and immune cell infiltration. It also represents a potential therapeutic target and marker for the diagnosis and prognosis of LUAD.  \nK E Y WO R D S  \nimmune checkpoint, immune infiltration, lung adenocarcinoma, POC1A, prognostic biomarker, tumour mutation burden  \nZi-Hao Li, Jia-Yi Li, and Zuo-Tao Wu contributed equally to this work.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.  \n1 | INTRODUCTION  \nIn the most recent cancer statistics released by the American Cancer Society, the study revealed approximately 2.2 million new cases of lung cancer, which represents the second highest number of new cancer cases, and approximately 1.8 million deaths ","cbCaifRqh4C0Vo23","https://ap.wps.com/l/cbCaifRqh4C0Vo23","pdf",20040400,16,"English","# Introduction\n# Background on LUAD and POC1A\n# Methods and data sources (TCGA, GEO)\n# Diagnostic and prognostic analyses (ROC, Kaplan–Meier)\n# Immune microenvironment and biomarkers (immune infiltration, TMB, checkpoints)\n# Experimental validation (RT-qPCR, IHC, cell assays)","[{\"question\":\"What is the main aim of the study on POC1A in lung adenocarcinoma?\",\"answer\":\"The study evaluates whether POC1A expression is associated with LUAD development, diagnosis performance, and poor prognosis, and explores related immune and genomic features.\"},{\"question\":\"How was POC1A diagnostic and prognostic value assessed?\",\"answer\":\"Differential expression was analyzed using TCGA and GEO, diagnostic performance was tested using ROC curve analysis, and prognostic value was evaluated using Kaplan–Meier survival analysis.\"},{\"question\":\"What experimental methods validated the findings for POC1A?\",\"answer\":\"POC1A expression was verified using real-time quantitative PCR and immunohistochemistry, and cell experiments tested effects of POC1A on proliferation, migration, and invasion.\"}]","Upregulation of POC1A in lung adenocarcinoma promotes tumour progression and predicts poor prognosis | PDF",1790039822,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7fa59c175cc9786b213c8a38b507c44.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/168e16b910cd522e229ba1639fb84234.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a04426bec22c2a957ac2a175c4db8132.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df0581a70dd8c6cffd5c0dc8da613c46.webp",980,1287]